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Background: Cervical cancer (CC) is one of the most widespread gynecological malignancies in women worldwide.
Treatment strategies and screening modalities have largely evolved these past years resulting in an improvement of
survival. However, treatment modalities are associated with long term side effects that significantly impacts quality
of life (QOL) in cervical cancer survivors. The aim of this study is to evaluate QOL (General and sexual QOL) in
cervical cancer survivors up to 10 years after the diagnosis.
Material and methods: In a cross-sectional descriptive study design, 110 cervical cancer survivors (CCS) and 80
healthy controls completed questionnaires assessing QOL.
Results: Participants were Arabic White, sexually active. The mean age at diagnosis was 34 years and was 43 years
at the time of the interview. In our series long term CCS have generally a good global QOL comparable with
healthy controls. However, issues concerning emotional functioning were over expressed by CCS. As to the sexual
impact of cervical cancer; CCS experienced less sexual functioning and enjoyment and less satisfaction with their
body image when compared to healthy controls.
In a multivariate analysis, spiritual well-being and social support were the predictor factors that statistically affected
QOL among the studied cohort, it accounted for 81 % of the variance in QOL scores.
Conclusions: A better understanding of the complexity of the relationship between QOL and cervical cancer
sequelae in one hand and socio-demographic factors in the other hand is necessary to improve QOL among
cervical cancer survivors. More efforts should make to inform disease free patients about expected side effects and
symptoms to face the physical changes that would affect their QOL and sexual activity.
Keywords: Long term cervical cancer survival, Quality of life, Sexual functioning, QLQ-C30, QLQ-CX24, Population
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Survivorship relationships between QOL and sequelae of
cervical cancer for women diagnosed during fertile age
are complex. It is important for health care professionals
to recognize that aspects of cancer survivorship require
attention and specific follow-up care.Background
Cervical cancer (CC) is one of the most widespread
gynecological malignancies in women worldwide [1]. In
Morocco, CC is the second most common cancer with* Correspondence: jihane.khalil@gmail.com
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oncology department of the national cancer institute.
Treatment strategies and screening modalities have
largely evolved these past years; consequently cervical
cancer is diagnosed at earlier stages where treatment is
more effective. Overall survival rates have in fact widely
increased; in the earlier stages 5-year relative survival is
estimated to be around 91.5 % [2].
With therapeutic progress come side effects; either it
is surgery, radiotherapy or chemotherapy literature has
widely described toxicities and side effects related to the
treatment adopted. Persistent negative effect on physical
and psychosocial functioning of the treatment especiallyis distributed under the terms of the Creative Commons Attribution 4.0
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in many studies [3–5].
After completion of treatment, cervical cancer survi-
vors (CCS) have to deal with treatment sequelae which
eventually lead to a deterioration of their quality of life
(QoL). Moreover, cervical cancer is mostly diagnosed
during the fertile age where the majority of patients are
sexually active [6]. Sexual activity in addition to self es-
teem is also highly influenced by the treatment received.
Therefore, discussions and planning of primary treat-
ment should address all of the QoL aspects.
In Morocco, unfortunately few studies and surveys
have addressed this question especially the sexuality is-
sues after cervical cancer, it is mostly due to religious be-
liefs and mores that make this subject a taboo for most
women.
Our study is aiming to analyze the impact of cervical
cancer on QOL and sexuality among long term cervical
cancer survivors.
Materials and methods
Study design and recruitment
Our study is a prospective one. Case eligibility included
women sexually active, diagnosed with cervical cancer
5–10 years earlier, aged between 17 and 45 at the time
of diagnosis and free of any recurrences or second
malignancies.
Women were identified during routine follow up.
The study was properly explained to eligible partici-
pants. After obtaining a written informed consent, the
study questionnaire was administered during 30 min by
physicians using appropriate words adapted to our pa-
tients mostly illiterates. For patients intimacy all inter-
views were conducted by female physicians.
Participants
Cases
Of the180 women recruited in this study, 70 patients de-
clined and 110 accepted to participate in the study.
Of the 110 patients included in the study, 55 com-
pleted the questionnaire in writing and provided signed
informed consent, the remaining patients provided their
answers verbally and the questionnaire was filled by the
physician in charge, their consent was provided either
verbally by 15 women or by fingerprinting in 40 cases.
Controls
To evaluate the results of CCS, random controls were
selected; eighty unaffected acquaintance controls com-
pleted the questionnaire.
Controls were mostly the accompanying persons of
the patients. Although we were unable to match at least
one control per case, the ascertained controls provide
valuable information regarding the used scales.Instruments
Quality of life
Quality of life was evaluated using the Arabic validated
version of the European Organization for Research and
Treatment of Cancer (EORTC) QOL Questionnaire,
QLQ-C30, which is a 30-item questionnaire assessing
the general QOL of cancer patients. It measures global
health, 5 functional domains (physical, role, cognitive,
emotional,and social), 3 symptom scales (fatigue, pain,
and nausea/vomiting), and 6 symptom or problem single-
item scales (dyspnea, insomnia, appetite loss, constipation,
diarrhea, and financial problems) [7, 8].
Sexual impact
Sexual impact on cervical cancer survivors (CCSs) was
evaluated using specific questionnaire elaborated and
validated by the EORTC (QLQ-CX24) that concerned
only CCSs. It contains three multi-item scales (symptom
experience, body image, and sexual/vaginal functioning)
and six single-item scales (lymphedema, peripheral neur-
opathy, menopausal symptoms, sexual worry, sexual ac-
tivity, and sexual enjoyment) [9].
Since the Arabic version is still not available in the
EORTC database we proceeded to a translation from
English to Arabic language. We used a method involving
translation and back-translation procedures, in collabor-
ation with professionals, psycho-oncologists and a trans-
lator/ linguist. A pilot test was performed. We asked a
random sample of 20 patients was studied to participate
in the study. All of them accepted and completed the
questionnaire. All of the patients and their accompany-
ing female’s persons found the questionnaire straightfor-
ward and easy to complete.
In addition to the aforementioned questionnaires, we
collected information concerning family, social and pro-
fessional status, comorbidity, education level and marital
status, number of children, life insurance and employ-
ment. Information regarding tumor stage and treatment
received were also required for our data collection.
Spiritual well-being
Spiritual well-being was measured by the Functional As-
sessment of Cancer Therapy-Spirituality Scale (FACT-Sp)
[10]. It is 12-item scale with three sub-domains of spiritual
well-being, which permit an in-depth exploration of the
components that constitute spiritual well-being (peace,
meaning, and faith).
This scale was mainly used to evaluate the spiritual
well being as a predictor factors affecting QOL in CCS.
Data collection and procedure
Routine follow up is performed in a dedicated unit to
gyneco-mammary malignancies; questionnaires were ad-
ministered to the participants in this special unit right
Table 1 Demographic characteristics of the studied cohort
Studied cohort Control arm
Mean age at diagnosis 34 years (range 17–43)
Mean age at the time of the
interview
43 years (range 25–53) 42 years
(range 23–51)
Marital status:
Married 100 %(n = 110) 100 %(n = 80)
Children
Yes 91 % (n = 100) 93 %(n = 74)
No 9 % (n = 10) 7 % (n = 6)
Number of children
< 3 34 %(n = 37) 26 % (n = 21)
> 3 66 %(n = 73) 74 % (n = 79)
Educational level
Illiterate 56 %(n = 61) 58 %(n = 46)
Elementary 14 %(n = 15) 11.6 %(n = 9)
Junior college 18 %(n = 20) 15.4 %(n = 13)
High school 13 %(n = 14) 15 %(n = 12)
Employment status:
Employed 28 %(n = 31) 20 %(n = 16)
Unemployed 72 %(n = 79) 80 %(n = 40)
Life Insurance:
Yes 89 %(n = 98) Not needed
No 11 %(n = 12)
Hospitalization during the last year:
Yes 8 %(n = 9) Not needed
No 92 %(n = 101)
Social support
Yes 76 %(n = 84) Not needed
No 24 %(n = 26)
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illiteracy, we could not proceed with a self-administration;
the questionnaires were explained properly by radiation
oncologists to each patient. All of the participants com-
pleted the questionnaires. Ultimately, 55 patients com-
pleted the questionnaire in writing while 50 % of the
cohort provided their answers verbally and the question-
naires were filled by the physician in charge.
Statistical analysis
The data were stored and analyzed using SPSS version
17.0 software (SPSS Inc., Chicago, IL, USA).
Univariate analysis (Pearson product moment correla-
tions) was used to determine the relationships between
the variables collected such as age, education level,
tumor stage. To account for multivariate relation of the
predictor variables to QOL, a stepwise multiple regres-
sion was performed.
In order to identify variables significantly linked to
QOL scores, we performed a multivariate analysis. The
alpha level was set at PV: 0.05 to determine statistical
significance.
Results
Demographic and clinical characteristics
The majority of the participants were married, Arabic
white, mostly illiterates in 56 % of the cases and
unemployed in 72 % of the cases. The mean age at diagno-
sis was 34 years (range 17–43) and 43 years (range 25–53)
at the time of the interview.
The average time between the year of diagnosis and
year of interview was 7.0 years (range: 4–11 years).
Tumor reported stages were IB in 4 % of the cases,
IIA, IIB, IIIA and IIIB in 14, 15, 20 and 47 % of the stud-
ied cohort. Treatment modalities included concurrent
radiochemotherapy in most of the cases (79 %), surgery
was performed in 21 % of the cohort; surgery only (4 %);
surgery and radiation (10 %); surgery, radiation, and
chemotherapy (7 %).
Eighty nine percent of the studied cohort had a life insur-
ance covering the whole treatment process. (Demographc
and clinical characteristics are detailed in Tables 1 and 2).
QOL scores of the studied cohort (Table 3)
QOL was assessed using the EORTC QLQ-C30 ques-
tionnaire. As indicated in Table 3, cervical cancer survi-
vors generally reported good global QOL, it was
particularly evident among the social, physical and role
functioning domains.
On the symptoms scales CCS showed a relatively low
level of problems, the most reported symptom was pain,
financial problems were also highly reported; although
concerning financial problems, we cannot conclude if
cancer is the main cause mostly because the majority ofthe included patients had already a low socioeconomic
level.
FACT-SP scale was also used to assess general QOL
among cervical cancer survivors. We did not find statis-
tical difference between the studied cohort and the
control arm, participants generally expressed a good
spiritual well being reflected in the three sub domains
(peace, meaning, and faith) of the scale used, only 17 %
of the studied cohort expressed low scores regarding the
peacefulness sub domain.
Comparison of QOL scores between cervical cancer
survivors and controls (Table 4)
Only few differences were noted between controls and
long term cervical survivors included in the study. Com-
pared with controls, CCS reported mostly a lower emo-
tional functioning on the QLQ-C30 scale (p = 0.0) and a
higher rate of constipation.
Table 2 Clinical characteristics of cervical cancer survivors
Percent Number
Tumor stage:
IB 4 % 4
IIA 14 % 15
IIB 15 % 17
IIIA 20 % 22
IIIB 47 % 52
Treatment modalities:
Surgery 21 % 23
Surgery only 4 % 4
Surgery + Radiotherapy 10 % 11
Surgery + Radiotherapy + Chemotherapy 7 % 8
Concurrent chemoradiotherapy 79 % 87
Brachytherapy 67 % 74
Table 4 Quality of life scores of cervical cancer survivors and
controls (Significant adjusted differences)
CCS Controls P
Global quality of life 71.07 ± 21.5 71.07 ± 21.5 0.15
Functional scales
Emotional functioning 75.8 ± 37.5 86.9 ± 29.7 0.001
Symptoms scales
Constipation 20.5 ± 39.8 12.3 ± 22.8 0.016
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Of the 110 cervical cancer survivors interviewed, 77
(61.6 %) were sexually active at the time of the interview.
Multiple reasons were reported by patients not sexually
active; 31 % of them reported having no interest in sex-
ual relations, 36 % did not have sexual partner, the fear
of developing a relapse or an infection was reported by
41 % of the cohort, fatigue, physical problems and other
reasons were reported in 10, 13 and 8 %.Table 3 The EORTC quality of life questionnaire (QLQC30) for
the studied cohort and controls
QLQ C 30 Patients Controls P value
Global quality of life 71.07 ± 21.5 74.8 ± 19.8 0.24
Functional scales, Mean ± SD
Physical functioning 78.1 ± 25.6 71.07 ± 21.5 0.15
Role functioning 76.8 ± 26.8 79.8 ± 24.6 0.45
Emotional functioning 75.8 ± 37.5 86.9 ± 29.7 0.001
Cognitive functioning 73.7 ± 25.6 84.7 ± 24.6 0.24
Social functioning 93.6 ± 21.5 91.5 ± 19.3 0.07
Symptom scales, Mean ± SD
Energy/Fatigue 15.6 ± 18.2 12.3 ± 8.4 0.26
Nausea and vomiting 2.9 ± 12.6 1.9 ± 5.6 0.15
Pain 21.1 ± 27.8 12.5 ± 6.7 0.49
Short of breath 8.4 ± 20.8 2.3 ± 5.8 0.43
Sleep disturbance 17.2 ± 31.3 8.5 ± 5.6 0.3
Lack of appetite 9.8 ± 20.3 7.6 ± 10.4 0.23
Constipation 20.5 ± 39.8 12.3 ± 22.8 0.016
Diarrhea 13.7 ± 39.3 5.6 ± 11.3 0.23
Financial problems 35.3 ± 38.2 27 ± 28.9 0.1
*P value relates to the comparison with the control armSome scales of the EORTC QLQ-CX24 questionnaire
had missing values because of variability concerning pa-
tient’s acceptance. Eventually, scales concerning Sexual/
Vaginal Functioning and Sexual Enjoyment were skipped
by 12 and 14 % of the studied cohort. Scales regarding
sexual worry and sexual activity had also missing values;
9 and 8 % of the women did not answer these questions.
When compared to the control arm CCS experienced
more lymphedema (P = 0.02), less sexual functioning and
enjoyment and less satisfaction with their body image.
Figure 1 illustrates differences concerning sexual func-
tioning between the two arms.
Predictors of quality of life
The resulting model of QOL outcomes suggests that
spiritual well-being significantly affects QOL in CCS.
Spiritual WB accounted for 81 % of the variance in QOL
scores of the sample.
We also analyzed demographic and clinical character-
istics to assess variables affecting QOL in CCS. In a uni-
variate analysis tumor stage and the treatment received
were defined as predictors of QOL; in fact advanced
tumor stage, brachytherapy and the absence of social
support were associated with lower scores of QOL-C30
and QOL-CX24 suggesting a poorer health related QOL
in CCS. In the multivariate analysis only social support
and spiritual WB were defined as predictors of QOL.
Discussion
These past years, oncologists have focused their efforts
on maximizing the overall survival of cervical cancer pa-
tients. Even if there is a general acknowledgement that
QOL is an important aspect of patient care, it is not the
main priority when recommending cancer treatment.
There is an increasing interest to evaluate and improve
QOL among CCS. In fact, many population-based stud-
ies have been enrolled to assess QOL among CCS and
to define factors affecting patient’s well being after the
diagnosis of cervical cancer.
To our knowledge, our series is the first population-
based study to assess QOL in long term Moroccan CCS
up to 10 years after cancer treatment.
The particularity of our series is that it concerns
Arabic female patients for whom sexuality is considered
Fig. 1 Disease-specific quality of life scores (EORTC QLQ-CX24) of cervical cancer survivors compared with controls
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cancer survivors is still not a priority.
In our study we characterized QOL issues of young,
long-term female cervical cancer survivors with a Mo-
roccan and also a Muslim perspective, thereby adding to
the literature a description of a group of women who
has not previously been studied.
As for most published data [5, 11–13], in our study
health related QOL in long term CCS was generally sat-
isfactory ; we did not find a statistical difference between
the studied cohort and healthy controls. Nevertheless,
emotional functioning was lower in CCS.
As anticipated, we could not assess correctly sexual
functioning of our patients; most of them expressed no
interest in having sexual activity, also many of the sexu-
ally active patients skipped some items in the question-
naire relative to sexual functioning. For whom who
completed the questionnaire, sexual functioning was
mostly compromised due to physical discomfort, in fact
cervical cancer survivors reported more discomfort than
controls with a higher incidence of hot flashes and vagi-
nal dryness.
As a result of our study, it is quite obvious that differ-
ence in sexual functioning between CCS and healthy
controls remains till 10 years after the diagnosis of cer-
vical cancer. Suggesting that cervical cancer survivors
continue to struggle with physical problems and discom-
fort which negatively affect their sexual functioning and
gynecologic health. These results are consistent with
those of other published studies [5, 14, 15]. Therefore,
gynecological care and sexual education after cervical
cancer treatment should an important component of the
initial treatment.
In fact, available guidelines strongly recommend sexual
education in CCS, they also suggest the use of dilators 2–4weeks after the completion of Radiotherapy treatment [16,
17]. In a recent review evaluating different interventions
used for psychosexual dysfunction in women treated for
gynaecological malignancy, oestrogen vaginal therapy ap-
peared to improve vaginal dryness [18].
Unfortunately in our daily practice sexual education is
still not a priority for many physicians, so are dilatators
that were not prescribed in any of the studied cases. Of
note, local hormonal therapy was prescribed in only
20 % of the cases with vaginal dryness.
We tried to find an explanation to the lack of the discus-
sion about sexual issues in CCS in our department, for
that we asked physicians why sexual education was not
performed and we gave them multiple choices of answers,
sample answers were 1/Not feeling comfortable talking
about sexuality with patients, 2/Patients are not interested,
3/ It is not a priority, 4/ Lack of time, the second and the
third choices were the most represented (47 and 52 %
respectively).
Many predictive factors for QOL in CCS have been
studied and published in the literature [5, 14, 15], as a
example Wenzel et al. found that spiritual well-being,
maladaptive coping, and reproductive concerns were
independently affecting QOL [5], other studies suggest
that social, family, and intimate relationship played a
crucial role on perception of QOL [19].
In our series, spiritual well being along with social
support significantly affected QOL in CCS.
Although we could not define a cause-and-effect rela-
tionship, it is reasonable to hypothesize that CCS who ex-
perience changes in their marital status after the diagnosis
of cervical cancer, are more likely to have lower QOL
scores. In our study, 39 % of CCS who were married when
diagnosed got divorced at the time of the interview.
Seventy two percent of them attributed their divorce to
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tigation regarding the stress that this disease causes to the
relationship.
Our study showed that the treatment modalities used did
not statistically affect health-related QoL or sexual func-
tioning, which is in contrast with other reports where sur-
gery was associated with less sexual dysfunction and better
QOL when compared to radiation therapy [11, 20–24]. In
our opinion, it is due to the fact that only 4 % of the studied
cohort had surgery alone as the main treatment, making
the statistical analysis not feasible.
This study has several limitations, in one hand only
two available scales were used to assess QOL(QLQ-
C30,QLQ-CX24) as Arabic validated version is still not
available for other scales such as SF36, Coping Orienta-
tions to Problems Experienced (COPE) scale, the Inter-
personal Support Evaluation List scale (ISEL)and Likert
scale for reproductive concerns, therefore we could not
define all predictor factors for QOL. On the other hand,
although our efforts to complete the QOL-CX24 relative
to sexual functioning, obtaining full acceptance of all the
patients was not achieved which made the evaluation of
sexual functioning incomplete.
Conclusion
Cervical cancer survivors are dealing each day with se-
quelae relative to their disease. A better understanding
of long-term QOL in cervical cancer survivors seems to
be crucial, especially that it will allow physicians to in-
form patients about what they could expect in a long
term. A literature review has in fact suggested that a well
informed patient deals better with treatment sequelae
[23]. Improving patient-doctor relationship, counseling
about cancer specific issues and sexual education should
be the major objectives in the initial patient’s care.
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